jannisborn commited on
Commit
d3ae257
1 Parent(s): 188d00f
Files changed (1) hide show
  1. model_cards/article.md +58 -2
model_cards/article.md CHANGED
@@ -11,7 +11,7 @@
11
 
12
  **Model Details**: GCPN is a graph-based molecular generative model that can be optimized with RL for goal-directed graph generation.
13
 
14
- **Developers**: Jiaxuan You and co-authors from Stanford.
15
 
16
  **Distributors**: Code provided by TorchDrug developers, wrapped and distributed by GT4SD Team (2023) from IBM Research.
17
 
@@ -31,7 +31,7 @@ Goal-Directed Molecular Graph Generation (NeurIPS 2018)](https://proceedings.neu
31
 
32
  **License**: TorchDrug: Apache-2.0 license.
33
 
34
- **Where to send questions or comments about the model**: Open an issue on [TorchDrug repository](https://github.com/DeepGraphLearning/torchdrug).
35
 
36
  **Intended Use. Use cases that were envisioned during development**: Chemical research, in particular drug discovery.
37
 
@@ -63,3 +63,59 @@ Model card prototype inspired by [Mitchell et al. (2019)](https://dl.acm.org/doi
63
  }
64
  ```
65
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11
 
12
  **Model Details**: GCPN is a graph-based molecular generative model that can be optimized with RL for goal-directed graph generation.
13
 
14
+ **Developers**: Jiaxuan You, Bowen Liu and co-authors from Stanford.
15
 
16
  **Distributors**: Code provided by TorchDrug developers, wrapped and distributed by GT4SD Team (2023) from IBM Research.
17
 
 
31
 
32
  **License**: TorchDrug: Apache-2.0 license.
33
 
34
+ **Where to send questions or comments about the model**: Open an issue on [TorchDrug repository](https://github.com/DeepGraphLearning/torchdrug) or ask original authors.
35
 
36
  **Intended Use. Use cases that were envisioned during development**: Chemical research, in particular drug discovery.
37
 
 
63
  }
64
  ```
65
 
66
+
67
+ # Model card -- GraphAF
68
+
69
+ **Model Details**: GraphAF is a flow-based autoregressive graph molecular generative model that can be optimized with RL for goal-directed graph generation.
70
+
71
+ **Developers**: Chence Shi, Minkai Xu and co-authors from Peking and Shanghai University and MILA.
72
+
73
+ **Distributors**: Code provided by TorchDrug developers, wrapped and distributed by GT4SD Team (2023) from IBM Research.
74
+
75
+ **Model date**: Published in 2020.
76
+
77
+ **Model version**: Models trained by GT4SD team on the tasks provided by TorchDrug repo [(see their tutorial)](https://torchdrug.ai/docs/tutorials/generation.html).
78
+ - **ZINC_250k**: 250,000 drug-like molecules with a maximum atom number of 38, taken from [ZINC](https://zinc.docking.org).
79
+ - **QED**: ZINC dataset, but the model was optimized with Proximal Policy Optimization (PPO) to generate molecules with high QED scores.
80
+ - **pLogP**: ZINC dataset, but the model was optimized with Proximal Policy Optimization (PPO) to generate molecules with high pLogP scores.
81
+
82
+ **Model type**: A flow-based autoregressive graph molecular generative model that can be optimized with RL for goal-directed graph generation.
83
+
84
+ **Information about training algorithms, parameters, fairness constraints or other applied approaches, and features**: Default parameters as provided in [(TorchDrug tutorial)](https://torchdrug.ai/docs/tutorials/generation.html).
85
+
86
+ **Paper or other resource for more information**: [GraphAF: a flow-based autoregressive model for molecular graph generation (*ICLR 2020*)](https://openreview.net/pdf?id=S1esMkHYPr).
87
+
88
+ **License**: TorchDrug: Apache-2.0 license.
89
+
90
+ **Where to send questions or comments about the model**: Open an issue on [TorchDrug repository](https://github.com/DeepGraphLearning/torchdrug) or ask original authors.
91
+
92
+ **Intended Use. Use cases that were envisioned during development**: Chemical research, in particular drug discovery.
93
+
94
+ **Primary intended uses/users**: Researchers and computational chemists using the model for model comparison or research exploration purposes.
95
+
96
+ **Out-of-scope use cases**: Production-level inference, producing molecules with harmful properties.
97
+
98
+ **Factors**: Not applicable.
99
+
100
+ **Metrics**: Validation loss on decoding correct molecules.
101
+
102
+ **Datasets**: 250,000 drug-like molecules from [ZINC](https://zinc.docking.org) (with a maximum atom number of 38).
103
+
104
+ **Ethical Considerations**: Unclear, please consult with original authors in case of questions.
105
+
106
+ **Caveats and Recommendations**: Unclear, please consult with original authors in case of questions.
107
+
108
+ Model card prototype inspired by [Mitchell et al. (2019)](https://dl.acm.org/doi/abs/10.1145/3287560.3287596?casa_token=XD4eHiE2cRUAAAAA:NL11gMa1hGPOUKTAbtXnbVQBDBbjxwcjGECF_i-WC_3g1aBgU1Hbz_f2b4kI_m1in-w__1ztGeHnwHs)
109
+
110
+ ## Citation
111
+
112
+ ```bib
113
+ @inproceedings{shi2020graphaf,
114
+ author = {Chence Shi and Minkai Xu and Zhaocheng Zhu and Weinan Zhang and Ming Zhang and Jian Tang},
115
+ title = {GraphAF: a Flow-based Autoregressive Model for Molecular Graph Generation},
116
+ booktitle = {International Conference on Learning Representations, {ICLR} 2020},
117
+ year = {2020},
118
+ url = {https://openreview.net/forum?id=S1esMkHYPr}
119
+ }
120
+ ```
121
+